Patients with known hypersensitivity to Albendazole or other Benzimidazole derivatives. Albendazole is known to be teratogenic and embryotoxic in some animals. Therefore it should not be administered during pregnancy or in women thought to be pregnant.
Women of childbearing should take the medication within 7 days after the start of menstruation.